GlassScriptPhysician profile
Brady Pederson
NPI 1841667763
$3,286.82
in general payments reported to CMS, 2019-2025
16 companies · $596 in 2025
The $596 reported for 2025 was more than what 81% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $348 · 2020: $209 · 2021: $146 · 2022: $339 · 2023: $498 · 2024: $1,151 · 2025: $596.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,245.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,245.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $1,254.32 | 2022-2025 | Infuse, Miebo, Xiidra |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $396.52 | 2019-2021 | |
| Alcon Vision LLC | $315.55 | 2019-2025 | Total30, Precision 1, Precision7 |
| Tarsus Pharmaceuticals, INC. | $312.42 | 2024-2025 | Xdemvy |
| Johnson & Johnson Vision Care, INC. | $245.58 | 2019-2025 | Acuvue |
| Biotissue Holdings INC. | $201.26 | 2024 | |
| Oyster Point Pharma, INC. | $116.39 | 2024-2025 | Tyrvaya |
| Coopervision INC. | $112.60 | 2020-2025 | Myday Contact Lens |
| Dompe US, INC. | $86.94 | 2024-2025 | Oxervate |
| Maculogix, INC. | $76.35 | 2019 | |
| Sun Pharmaceutical Industries INC. | $52.64 | 2023-2025 | Cequa |
| Thea Pharma INC. | $43.06 | 2022 | |
| Abbvie INC. | $23.05 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $18.49 | 2021 | |
| Optos, INC. | $16.57 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tearlab Corp | $15.08 | 2023 | Tearlab Osmolarity System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brady Pederson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.